Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/920148/000092014810000021/labcorp10k.htm
Exhibit 99.1
Laboratory Corporation of America® Holdings
358 South Main Street
Burlington, NC 27215
Telephone: (336) 584-5171
www.labcorp.com
FOR IMMEDIATE RELEASE
Contact: Stephen Anderson - 336-436-5274
Investor@labcorp.com
LABORATORY CORPORATION OF AMERICA® HOLDINGS
ANNOUNCES 2009 FOURTH QUARTER AND FULL YEAR RESULTS
Revenue Growth Drives Adjusted EPS of $1.16 and
Operating Cash Flow of $224.7 Million
Burlington, NC, February 11, 2010 — Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today
announced results for the quarter and year ended December 31, 2009.
Fourth Quarter Results
Net earnings were $142.7 million, compared to $118.1 million in the fourth quarter of 2008. Earnings per diluted share (EPS) were $1.33 compared to $1.08 in 2008. Earnings per diluted share, excluding restructuring and other special charges recorded in both periods (Adjusted EPS) were $1.16, compared to $1.10 in 2008.
Operating income was $215.8 million. Operating income, excluding restructuring and other special charges (Adjusted Operating Income) was $221.9 million, or 19.0% of net sales.
Compared to the fourth quarter of 2008, and excluding a special charge in the prior year, revenues were $1,165.1 million, an increase of 3.4%. Testing volume, measured by accessions, decreased 0.9% and revenue per accession increased 4.3%. Excluding the special charge and the consolidation of the
Company’s Ontario, Canada joint venture, revenue increased 2.8%. Testing volume decreased by 1.5% and revenue per accession increased 4.3%. During the quarter, the termination of two large government contracts reduced volume by 1.5%, declines in the Company’s drugs of abuse testing business reduced volume by 0.4% and weather reduced volume by 0.3%. Excluding these items, volume increased by 0.7% in the quarter.
-more-
The following information was filed by Laboratory Corp Of America Holdings (LH) on Thursday, February 11, 2010 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Laboratory Corp Of America Holdings's financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Laboratory Corp Of America Holdings.
Laboratory Corp Of America Holdings
Email AlertsAnnual Reports
- 10-K Annual Report February 2019
- 10-K Annual Report February 2018
- 10-K Annual Report February 2017
- 10-K Annual Report February 2016
- 10-K Annual Report February 2015
- 10-K Annual Report February 2014
- 10-K Annual Report February 2013
- 10-K Annual Report February 2012
- 10-K Annual Report March 2011
-
10-K Annual Report February 2010
Material Contracts, Statements, Certifications & more
Laboratory Corp Of America Holdings provided additional information to their SEC Filing as exhibits
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Form Type: 10-K Annual Report
Accession Number: 0000920148-10-000021
Submitted to the SEC: Wed Feb 24 2010 3:21:17 PM EST
Accepted by the SEC: Wed Feb 24 2010
Period: Thursday, December 31, 2009
Industry: Medical Laboratories
External Resources:
Insider Transactions
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/lh/0000920148-10-000021.htm
